A lipidomic view of SARS-CoV-2
Open Access
- 5 August 2021
- journal article
- editorial
- Published by Portland Press Ltd. in Bioscience Reports
- Vol. 41 (8)
Abstract
The global pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which started in late 2019, has caused huge social and economic losses. A growing number of investigators are focusing on understanding the interaction of SARS-CoV-2 with host cellular processes to find therapeutic approaches. New data suggest that lipid metabolism may play a significant role in regulating the response of immune cells like macrophages to viral infection, thereby affecting the outcome of the disease. Therefore, understanding the role of lipid metabolism could help develop new therapeutic approaches to mitigate the social and economic cost of coronavirus disease 2019 (COVID-19).Keywords
This publication has 40 references indexed in Scilit:
- Cholesterol, inflammation and innate immunityNature Reviews Immunology, 2015
- Lipids and lipid management in diabetesBest Practice & Research Clinical Endocrinology & Metabolism, 2014
- The inflammatory profile and liver damage of a sucrose-rich diet in miceThe Journal of Nutritional Biochemistry, 2014
- High Density Lipoprotein: Assembly, Structure, Cargo, and FunctionsISRN Physiology, 2013
- Aging affects high-density lipoprotein composition and functionBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2013
- Richness of human gut microbiome correlates with metabolic markersNature, 2013
- Commensal bacteria at the interface of host metabolism and the immune systemNature Immunology, 2013
- New insights into the mechanism of low high-density lipoprotein cholesterol in obesityLipids in Health and Disease, 2011
- Lipoproteins, cholesterol homeostasis and cardiac healthInternational Journal of Biological Sciences, 2009
- The Mechanism of the Remodeling of High Density Lipoproteins by Phospholipid Transfer ProteinJournal of Biological Chemistry, 2001